awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51198443-6F88D1E8-0AE1-4085-8423-98EA0DD2AA34
Q51198443-6F88D1E8-0AE1-4085-8423-98EA0DD2AA34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51198443-6F88D1E8-0AE1-4085-8423-98EA0DD2AA34
[Advances of treatment of small cell lung cancer in 2012 American Society of Clinical Oncology Annual Meeting].
P2860
Q51198443-6F88D1E8-0AE1-4085-8423-98EA0DD2AA34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51198443-6F88D1E8-0AE1-4085-8423-98EA0DD2AA34
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b432cf3e75220a36fd1d4b8269c73ac2ee0e78b7
P2860
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancer.